Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07631039

LOGOGRAM: Validation of Allergy Care Flowcharts in Primary Care: Experience From Occitanie

This study, aimed at validating decision trees developed through collaboration between general practitioners and allergists, seeks to provide French data to optimize care pathways for patients with allergic diseases from the primary care level and to reduce the delays and negative consequences associated with incorrect diagnoses. Most patients with allergic conditions are initially seen in primary care, often during exacerbations. Although allergies, in their many clinical forms, account for approximately 6-8% of primary care consultations, clinicians frequently receive little or no formal training in this field and may not be fully aware of the latest evidence, associated risks, or appropriate referral pathways. These gaps can significantly affect the quality of care and patients' quality of life, while also contributing to higher morbidity and mortality. In this context, the European Academy of Allergy and Clinical Immunology established a multidisciplinary task force to transform existing allergy guidelines into simple, practical, and accessible tools to facilitate diagnosis and management in primary care. The group developed five decision trees covering asthma, anaphylaxis, drug allergy, food allergy, rhinitis, and urticaria to support primary care physicians and other non-specialists in managing patients with symptoms suggestive of allergic or hypersensitivity reactions. The results of this project will be directly applicable to the daily clinical practice of general practitioners in France and could serve as a model for replication in other regions and countries, although adaptations may be required depending on national healthcare systems.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

1 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Msp Espace Sante Servian, Béziers, Occitanie, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with suspected asthma, anaphylaxis, drug allergy, food allergy, rhinitis and urticaria.
  • Patients aged 1 year or older at inclusion, registered with a health insurance plan.
  • Patient or legal representative of the minor patient who agrees to participate in the research.

Exclusion criteria

  • Adults placed under guardianship or curatorship.
  • Patients already followed by an allergist and/or a specialist doctor for their allergies.
  • Patients who participate in a clinical research study relating to an antiallergic medication, immunosuppressant, immunomodulator in the year preceding their consultation visit with the GP.

Treatment and study plan

Implementation of an innovative tool based around AI-automated decision trees on an application

Other

The application provides immediate access to the algorithms (decision trees). Investigators can access a dedicated interface and enter participant data, including the suspected diagnosis, symptoms, acute episode or history of allergic disease, and the medical decision made (diagnosis, therapeutic management, or referral to a specialist). Management options based on the five algorithms are then generated to support physicians in the diagnosis and management of allergic diseases.

Primary outcomes

  1. Rate of referral to allergy specialists following primary care consultations for allergic diseases

    Time frame: through study completion, an average of 4 years

    Comparison of the proportion of patients referred to an allergy specialist by general practitioners after consultations for suspected allergic diseases before and after implementation of the clinical decision trees in participating centers.

Secondary outcomes

  1. Ease of use of the clinical decision trees

    Time frame: through study completion, an average of 4 years

    The ease of use of the clinical decision trees will be assessed using an online questionnaire completed by general practitioners at the end of their participation. The questionnaire will evaluate ease of use (score from 1 to 5, from very difficult to very easy), precision of the clinical decision trees (score from 1 to 5, from inaccurate to very precise), confidence felt during their application in clinical practice (score from 1 to 5, from not confident at all to totally confident), average duration of use (minutes), and willingness to continue using the clinical decision trees in routine practice (yes/no).

Study contacts

Contact information is provided by the study sponsor or research team.

Pascal DEMOLY, Pr

CONTACT

[email protected]

+33467336107

Sponsors and collaborators

Lead sponsor

University Hospital, Montpellier

Other

Registry information

Official study title

Validation Des Diagrammes de Flux d'Allergies en Soins Primaires : expérience de la région Occitanie

Acronym: LOGOGRAM

Important dates

Study start
2026
Primary completion
2030
Study completion
2030
First posted
Jun 5, 2026
Registry last updated
Jun 5, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.